HEMEROTECA. SINOPSIS DE ARTÍCULOS DEL DR. EDUARDO BLASCO OLAETXEA

​

http://www.laprovincia.es/secciones/noticia.jsp?pRef=2008060700_5_156106__Sociedad-y-Futuro-ciencia-busca-hacer-diana-cancer

PUBLICACIONES

http://www.ncbi.nlm.nih.gov/pubmed/20928978

Invest Clin. 2010 Jun;51(2):193-208.
Human papilloma virus and cervical cancer. An historical review on the development of research on cancer of the cervix uteri in Venezuela
García-Tamayo J, Molina J, Blasco-Olaetxea E.

http://www.ncbi.nlm.nih.gov/pubmed/19662819

Invest Clin. 2009 Jun;50(2):241-50.
[Importance of immunohistochemical studies in the diagnosis and the prognostic evaluation of cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix. Review].
García-Tamayo J, Molina J, Blasco-Olaetxea E.

http://www.ncbi.nlm.nih.gov/pubmed/18411196

Clin Transl Oncol. 2008 Apr;10(4):227-30.
Expression of blood group-related antigens in neoplastic uterine cervix.
Guzmán-Bistoni C, Pinillos B, Blanco-Arias MC, Arenas de Sotolongo A, Molina J, García-Tamayo J, Blasco-Olaetxea E.

http://www.ncbi.nlm.nih.gov/pubmed/17176905

Invest Clin. 2006 Dec;47(4):371-83.
Importance of E-cadherin; expression in the inmunohistochemical diagnosis of breast cancer
García Tamayo J, Blasco Olaetxea E, Morales A, Molina J, Guzmán Bistoni C, Méndez V.

http://www.ncbi.nlm.nih.gov/pubmed/9527390

Invest Clin. 1997 Dec;38(4):227-59.
[Application of electron microscopy and immunohistochemistry to the study of malignant tumors: a review of their diagnostic importance].

García-Tamayo J, Caleiras E, Blasco-Olaetxea E, Parada D, de García SE.

http://www.ncbi.nlm.nih.gov/pubmed/9463280

Arch Esp Urol. 1997 Oct;50(8):831-6.
[The proliferating nuclear fraction as a prognostic factor in superficial bladder carcinomas].
Belloso L, Zugasti A, Urkia M, Arozena F, Blasco-Olaetxea E.

http://www.ncbi.nlm.nih.gov/pubmed/8814689

Eur J Cancer. 1996 Mar;32A(3):444-6.
Superficial bladder cancer: study of the proliferative nuclear fraction as a prognostic factor.
Blasco-Olaetxea E, Belloso L, Garcia-Tamayo J.


http://www.ncbi.nlm.nih.gov/pubmed/8687160

Anticancer Res. 1996 Mar-Apr;16(2):963-7.
Prognostic significance of high expression of proliferating cell nuclear antigen in patients with intestinal metaplasia.
Blasco-Olaetxea E, Loizate A, Eizagirre B, Garcia-Tamayo J.

http://www.ncbi.nlm.nih.gov/pubmed/2064423

Arch Esp Urol. 1991 Jan-Feb;44(1):47-52.
Prognostic markers in transitional carcinoma of the bladder
Blasco Olaetxea E, Gutiérrez-Hoyos A, Garrido C, Arozena F.

http://www.ncbi.nlm.nih.gov/pubmed/1827730

Eur J Cancer. 1991;27(4):501-3.
Expression of type 1 blood group precursor in human gastric carcinoma.
Blasco Olaetxea E, Gutierrez-Hoyos A, Lojendio M, Cosme A, Arenas JI.

http://www.ncbi.nlm.nih.gov/pubmed/2208033

Cancer. 1990 Oct 15;66(8):1769-74.
Lewis system alterations in gastric carcinogenesis.
Torrado J, Blasco Olaetxea E, Gutierrez-Hoyos A, Cosme A, Lojendio M, Arenas JI.

http://www.ncbi.nlm.nih.gov/pubmed/2247887

Tissue Antigens. 1990 Jul;36(1):8-11.
Immunohistological patterns of blood group ABO and type 1 chain (Lewis a Lewis b) and type 2 chain (H-2, Y) antigens in normal uterine cervix.
Torrado J, Gutierrez Hoyos A, Blasco Olaetxea E, Larraz J, Fernandez Rivas JL.


http://www.ncbi.nlm.nih.gov/pubmed/2117317

Virchows Arch A Pathol Anat Histopathol. 1990;417(3):277-8.
Altered expression of Lewis blood group and related antigens in fetal, normal adult and malignant tissues of the uterine endometrium.
Torrado J, Blasco Olaetxea E, Gutierrez-Hoyos A.

http://www.ncbi.nlm.nih.gov/pubmed/2929509
Am J Clin Pathol. 1989 Apr;91(4):503.
Ulex Europaeus (UEA 1)
Torrado J, Blasco Olaetxea E, Gutierrez-Hoyos A.

http://www.ncbi.nlm.nih.gov/pubmed/2923092

Am J Clin Pathol. 1989 Mar;91(3):249-54.
Expression of type 1 and type 2 blood group-related antigens in normal and neoplastic gastric mucosa.
Torrado J, Blasco Olaetxea E, Cosme A, Gutierrez-Hoyos A, Arenas JI.


http://www.ncbi.nlm.nih.gov/pubmed/2476347

Exp Cell Biol. 1989;57(3):153-8.
Expression of Lewis antigenic determinants in colorectal adenocarcinomas.
Blasco Olaetxea E, Torrado J, Cosme A, Alvarez E, Zugasti A, Gutierrez-Hoyos A, Arenas JI.

http://www.ncbi.nlm.nih.gov/pubmed/3342368

Cancer. 1988 Mar 15;61(6):1091-5.
T-antigen. A prognostic indicator of high recurrence index in transitional carcinoma of the bladder.
Blasco Olaetxea E, Torrado J, Belloso L, Arocena F, Gutierrez-Hoyos A, Cuadrado E.

http://www.ncbi.nlm.nih.gov/pubmed/3452910

Rev Fr Transfus Immunohematol. 1987 Dec;30(5):693-8.
Immunohistologic reactions of 20 monoclonal antibodies against non-A, non-B glycoconjugates with normal mucosae of the human gut.
Torrado J, Blasco Olaetxea E, Cosme A, Gutierrez-Hoyos A, Arenas JI, Cuadrado E.

http://www.ncbi.nlm.nih.gov/pubmed/3511295

J Urol. 1986 Feb;135(2):409-15.
Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study.
Cuadrado E, Rodriguez-Trinidad A, Blasco Olaetxea  E, Torrado J, Lopez Garcia JA, Arozena F.

http://www.ncbi.nlm.nih.gov/pubmed/3904638


Arch Esp Urol. 1985 May-Jun;38(3):291-9.
[Antigens of the ABO blood group in the bladder urothelium: comparison of 3 technics for its detection].
Cuadrado E, Rodríguez-Trinidad A, Blasco Olaetxea E, Torrado J.